PVLA – palvella therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PVLA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/16

03:21 pm

pvla

Palvella Therapeutics (PVLA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $210.00 price target on the stock.

Low Report

Palvella Therapeutics (PVLA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $210.00 price target on the stock.

Report

3/16

03:15 pm

pvla

Rating for PVLA

Low Report

Rating for PVLA

Report

2/25

12:23 pm

pvla

Rating for PVLA

Medium Report

Rating for PVLA

Report

2/25

12:23 pm

pvla

Rating for PVLA

Medium Report

Rating for PVLA

Report

2/25

04:33 am

pvla

Rating for PVLA

Medium Report

Rating for PVLA

Report

2/24

01:59 pm

pvla

Rating for PVLA

Low Report

Rating for PVLA

Report

2/24

11:06 am

pvla

Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Medium Report

Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Report

1/29

08:03 am

pvla

Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $192.00 price target on the stock.

Low Report

Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $192.00 price target on the stock.

Report

1/29

07:32 am

pvla

Rating for PVLA

Medium Report

Rating for PVLA

Report

1/16

12:28 pm

pvla

Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $192.00 price target on the stock.

Low Report

Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $192.00 price target on the stock.

Report

1/16

12:25 pm

pvla

Rating for PVLA

Low Report

Rating for PVLA

Report

1/7

08:02 am

pvla

Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $205.00 price target on the stock.

Medium Report

Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $205.00 price target on the stock.

Report

1/7

08:02 am

pvla

Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $205.00 price target on the stock.

Medium Report

Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $205.00 price target on the stock.

Report

1/7

07:32 am

pvla

Rating for PVLA

Medium Report

Rating for PVLA

Report

1/7

07:32 am

pvla

Rating for PVLA

Medium Report

Rating for PVLA

Report

1/7

05:53 am

pvla

Palvella Therapeutics initiated with an Outperform at Mizuho

Medium Report

Palvella Therapeutics initiated with an Outperform at Mizuho

Report

1/7

05:53 am

pvla

Palvella Therapeutics initiated with an Outperform at Mizuho

Medium Report

Palvella Therapeutics initiated with an Outperform at Mizuho

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.